Clinical view of regulation

Almost every industry in India has been wary of regulation and monitoring and no one more so than the country's clinical research industry. In fact, clinical research companies, which experiment or test medicines on humans, is turning bitter about government surveillance not least because of the stringent conditions and strong criticism, even from the Supreme Court, for various unethical practices that have led to increasing incidents of deaths. But the complaints have now descended to carping, so much so that the managing director of a leading Ahmedabad-based clinical research organisation said, "The government in this country wants to regulate everything, except Bollywood and politics."